Journals / Fizyoterapi Rehabilitasyon / 2005 / Cilt: 16 - Sayı: 1

Comparison of different mobility assessment indexes in adult patients with neuromuscular diseases

Erişkin nöromusküler hastalıklarda farklı mobilite değerlendirme yöntemlerinin karşılaştırılması

Pages
10–16
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

While RMI score increased parallel to the development of lower extremity muscle strength and timed performance test (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: This study was done to compare validity and reliability in evaluating the time related mobility level and sensitivity to changes of the Clinical Mobility Scale (CMS), Hauser Ambulation Index (HAI) and Rivermead Mobility Index (RMI) in patients with neuromuscular diseases.
📊
Key Findings & Data:Dynamometric muscle test to the lower extremity muscles and timed performance tests were applied.
💡
Conclusion & Impact:While RMI score increased parallel to the development of lower extremity muscle strength and timed performance test (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: This study was done to compare validity and reliability in evaluating the time related mobility level and sensitivity to changes of the Clinical Mobility Scale (CMS), Hauser Ambulation Index (HAI) and Rivermead Mobility Index (RMI) in patients with neuromuscular diseases. Materials and Methods: Fifty-two adult patients who had muscle weakness due to muscular dystrophy and myopathy and similar mobility levels were admitted in the study. Dynamometric muscle test to the lower extremity muscles and timed performance tests were applied. Moreover CMS, HAI and the Turkish version of RMI were used to evaluate the mobility. All the assessments were repeated by the same physiotherapist at 1st and 8th weeks after the beginning of the study. According to first evaluation results an appropriate home exercise program was given to the patients. Results: It was seen that all three mobility methods had high test-retest reliability and their relationship was significant with each other during the study for three evaluations. While RMI score increased parallel to the development of lower extremity muscle strength and timed performance test (p

Özet

Amaç: Bu çalışma nöromusküler hastalıklarda mobilite düzeyinin değerlendirilmesinde Klinik Mobilite Ölçeği (KMÖ), Hauser Ambülasyon İndeksi (HAİ) ve Rivermead Mobilite İndeksinin (RMİ) geçerlik, güvenirlik ve zaman içinde oluşan değişikliklere karşı hassasiyetlerini karşılaştırmak amacıyla yapıldı. Gereç ve yöntem: Çalışmaya kas tutulumu ile seyreden, benzer mobilite düzeyine sahip myopati ve musküler distrofili 52 erişkin hasta alındı. Alt ekstremite kaslarına dinamometrik kas testi, süreli performans testleri uygulandı. Mobiliteyi değerlendirmek üzere KMÖ, HAİ ve RMİ'nin Türkçe versiyonu kullanıldı. Değerlendirmeler başlangıçta, 1. ve 8. haftalarda aynı fizyoterapist tarafından tekrarlandı. Başlangıçta yapılan değerlendirmelerin sonuçlarına göre hastalara uygun ev programı verildi. Sonuçlar: Çalışma boyunca yapılan üç değerlendirme sonucunda, her üç mobilite yönteminin de test-tekrar test güvenirliklerinin yüksek olduğu, birbirleri arasında anlamlı bir ilişki bulunduğu görüldü. Sekiz haftalık değerlendirme sonrasında RMİ puanları total alt ekstremite kas kuvveti ve süreli performanstaki gelişimle (çömelip kalkma süresi ve 2 dakika yürüme mesafesi hariç) paralel olarak artarken (p

🔖

Cite This Article

KILINÇ, M., KIRDI, N., YILDIRIM, A. S., YAKUT, Y., ATAY, S., TAN, E. (2022). Comparison of different mobility assessment indexes in adult patients with neuromuscular diseases. Fizyoterapi Rehabilitasyon, Cilt: 16 - Sayı: 1, 10–16. https://ajindex.com/articles/516944

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. De Lisa JA, Gans BM. Rehabilitation Medicine and Principles and Practice. 3th. Ed. Philadelphia: Lippincott Williams and Wilkins; 1998:1557-1568
  2. Creason NS, Pogue NJ, Nelson AA, et al. Validating the nursing diagnosis of impaired physical mobility. Nurs Clin North Am. 1985;20:669-683
  3. Natterlund B, Ahlstrom G. Activities of daily living and quality of life in person with muscular dystrophy. J Rehabil Med. 2001;33:206-211
  4. Guccione AA. Physical therapy for musculoskeletal syndromes. Rheum Dis Clin North Am. 1996;22:551- 562
  5. Tinetti ME, Ginter SF. Identifying mobility dysfunctions in elderly patients: standard neuromuscular examination or direct assessment? JAMA. 1988;259:1190-1193
  6. Padua L, Schenone A, Aprile I, et al. Quality of life and disability assessment in neuropathy: a multicentre study. J Peripher Nerv Syst. 2005;10:3-10
  7. Vinci P. Gait rehabilitation in a patient affected with Charcot-Marie-Tooth disease associated with pyramidal and cerebellar features and blindness. Arch Phys Med Rehabil. 2003;84:762-765
  8. Padua L, Aprile I, Caliandro P. Intravenous immunoglobulin treatment in autoimmune neurological disorders: pilot study on early effects on patients’ quality of life. J Peripher Nerv Syst. 2004;9:3-6
  9. Bennekom CA, Jelles F, Lankhorst GJ. Rehabilitation Actives Profile: the ICIDH as a framework for a problem–oriented assessment method in rehabilitation medicine. Disabil Rehabil. 1995;17:169-175
  10. Rossier P, Wade DT. Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. Arch Phys Med Rehabil. 2001;82:9-13
  11. Paolucci S, Grasso MG, Antonucci G, et al. Mobility status after inpatient stroke rehabilitation: 1-year followup and prognostic factors. Arch Phys Med Rehabil. 2001;82:2-8
  12. Akın B, Emiroglu ON. Geriatriklerde Rivermead Mobilite İndeksinin Türkçe adaptasyonunun geçerlik ve güvenirliği. I. Ulusal Geriatri Kongresi Kongre Kitabı, 2002, 165
  13. Nicholas JA. Characterisation of a strength measurement device. Proceedings of the Orthopedic Research Society. 33rd Annual Meeting, 1987, 19-22
  14. Allsop KG, Ziter FA. Loss of strength and functional decline in Duchenne’s dystrophy. Arch Neurol. 1981;38:406-411
  15. Sugarbaker PH, Barofsky I, Rosenberg SA, et al. Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery. 1982;91:17-23
  16. Bernet–Bernady P, Preux PM, Preux C, et al. Case study of 199 patients with multiple sclerosis: